Changchun BCHT Biotechnology Co.

The Herpes Zoster Vaccine, Live produced by BCHT was approved for marketing in January 2023 which is the world's first Herpes Zoster Vaccine, Live for people aged at or above 40 years old, it fills the gap in domestic herpes zoster vaccines market.

Influenza Vaccine, Live, Nasal, Freeze-dried (launched in 2020), a novel influenza attenuated live vaccine, is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccine(GAP), it fills the gap in domestic influenza attenuated live vaccines market and has broad m...

In 2008, BCHT successfully launched Varicella Vaccine, Live which owned independent intellectual property, its shelf-life up to 36 months which is the longest one in the world, the market share rank first for many years in China.